Within the tumor microenvironment (TME), where myeloid and T cells demonstrate preferential glucose uptake over malignant cells (14), the secreted protein FGA orchestrates tumor matrix remodeling and immune response modulation through xCT expression regulation, thereby shaping clinical prognosis. This evidence concerns the gene FGA and neoplasm.